Minocycline Protects Cardiac Myocytes Against Simulated Ischemia–Reperfusion Injury by Inhibiting Poly(ADP-ribose) Polymerase-1
Authors:
- 1 December 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 56 (6) , 659-668
Abstract
There is an increase in reactive oxygen and nitrogen species in cardiomyocytes during myocardial ischemia/reperfusion injury. This leads to oxidative DNA damage and activation of nuclear repair enzymes such as poly(ADP-ribose) polymerase-1 (PARP-1). PARP-1 activation promotes DNA repair under normal conditions. However, excessive activation of PARP-1 leads to cell death. We report that PARP-1 enzymatic activity is directly inhibited by minocycline, and we propose that one mechanism of minocycline cardioprotection is the result of PARP-1 inhibition. Using cultured adult rat cardiac myocytes, we evaluated the mechanism of minocycline protection in which PARP-1 activation was induced by simulated ischemia/reperfusion injury using oxygen-glucose deprivation. We found an increase in reactive oxygen species production, PARP-1 activation, and PARP-1-mediated cell death after simulated ischemia/reperfusion. Cell death was significantly reduced by the PARP inhibitors 3, 4-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2H)-isoquinolinone (10 μM) and PJ-34 (500 nM) or by minocycline (500 nM). Cellular NAD+ depletion and poly(ADP-ribose) formation, which are biochemical markers of PARP-1 activation, were also blocked by minocycline. Finally, simulated ischemia/reperfusion led to induction of the mitochondrial permeability transition, which was prevented by minocycline. Therefore, we propose that the protective effect of minocycline on cardiac myocyte survival is the result of inhibition of PARP-1 activity.Keywords
This publication has 40 references indexed in Scilit:
- NAD+Depletion Is Necessary and Sufficient forPoly(ADP-Ribose) Polymerase-1-Mediated Neuronal DeathThe Journal of Neuroscience, 2010
- Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytesBiochemical and Biophysical Research Communications, 2007
- Differences among cell types in NAD+ compartmentalization: A comparison of neurons, astrocytes, and cardiac myocytesJournal of Neuroscience Research, 2007
- Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrationsProceedings of the National Academy of Sciences, 2006
- Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical‐scavenging activityJournal of Neurochemistry, 2005
- Minocycline Up-regulates Bcl-2 and Protects against Cell Death in MitochondriaJournal of Biological Chemistry, 2004
- Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing FactorScience, 2002
- Neonatal Mouse Cardiac Myocytes Exhibit Cardioprotection Induced by Hypoxic and Pharmacologic Preconditioning and by Transgenic Overexpression of Human Cu/Zn Superoxide DismutaseJournal of Molecular and Cellular Cardiology, 2000
- Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusionTrends in Pharmacological Sciences, 1998
- Cardiac Tamponade Caused by a Stab Wound with a Sewing Needle Left in a KimonoAmerican Journal of Forensic Medicine & Pathology, 1993